Sarcoma
📧 Sign up to get email alerts when something new happens for Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: A Study of SB939 in Patients With Translocation-Associated Recurrent/Metastatic Sarcomas [Phase 2]
Phase 2 clinical trial update for SB939 in translocation-associated recurrent/metastatic sarcomas has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor [Phase 3]
A Phase 3 trial comparing combination chemotherapy regimens in patients with Ewing's Sarcoma/PNET, completed.
-
CLINICAL_TRIALS research · 2023-08-01Clinical Trial Update: Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers [NA]
Feasibility and preliminary efficacy study of a mindfulness-based intervention for children and young adults with high-grade or high-risk ca…
-
CLINICAL_TRIALS trial_result · 2023-07-19Clinical Trial Update: Phase Ib/II Study of Fluzoparib in Combination With Dalpiciclib in Patients With Locally Advanced or Metastatic Sarcoma [Phase 2]
Phase Ib/II study update evaluating fluzoparib in combination with dalpiciclib for locally advanced or metastatic sarcoma (Phase 2).
-
CLINICAL_TRIALS trial_result · 2023-07-13Clinical Trial Update: A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) [Phase 1, Phase 2]
Clinical trial update for KVA12123 as a standalone and in combination with pembrolizumab in advanced solid tumors; current status is unknown…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-06-26Clinical Trial Update: Rosiglitazone in Treating Patients With Liposarcoma [Phase 2]
Phase 2 clinical trial evaluating rosiglitazone in patients with liposarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue [Phase 1, Phase 2]
Phase 1/2 trial evaluating maximal tolerated dose, safety, and efficacy of CPI-613 (Devimistat) with hydroxychloroquine in relapsed or refra…
-
CLINICAL_TRIALS trial_result · 2023-04-24Clinical Trial Update: Surgery With or Without Radiation Therapy in Untreated Nonmetastatic Retroperitoneal Sarcoma [NA]
A completed clinical trial comparing surgery with or without radiation therapy in untreated nonmetastatic retroperitoneal sarcoma; results p…
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Surufatinib in Patients With Osteosarcoma and Soft Tissue Sarcoma [Phase 2]
A Phase 2 clinical trial update for surufatinib in patients with sarcoma including osteosarcoma and soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: REVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor Malignancies [Phase 1, Phase 2]
Phase 1/2 trial REVEAL exploring NKTR-262 with NKTR-214 and nivolumab in various locally advanced/metastatic solid tumors was terminated; re…
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: Hyper-Thermia Enhanced Anti-tumor Efficacy of Trabectedin [Phase 2]
Phase 2 trial update suggesting hyper-thermia may enhance anti-tumor efficacy of trabectedin in sarcoma.
-
CLINICAL_TRIALS trial_result · 2023-01-05Clinical Trial Update: Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors [Phase 1, Phase 2]
Phase 1/2 safety study of Enapotamab Vedotin in solid tumors, including ovarian and cervical cancer; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers [Phase 1, Phase 2]
Phase 1/2 trial evaluating tremelimumab and IV durvalumab with Poly-ICLC in biopsy-accessible cancers; completed with results posted in 2022…
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update for T3011 administered intratumorally in advanced solid tumors, including phase 1 and phase 2 cohorts.
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluated vorinostat in combination with gemcitabine and docetaxel for advanced sarcoma; the study has completed with resu…
-
CLINICAL_TRIALS trial_result · 2022-09-10Clinical Trial Update: Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy [Phase 2]
Phase 2 trial evaluating regorafenib in metastatic solid tumors that progressed after standard therapy has completed, with multiple indicate…
-
CLINICAL_TRIALS trial_result · 2022-08-08Clinical Trial Update: Progressive Resistance Training for the Improvement of Physical Function [NA]
Clinical trial on progressive resistance training for improving physical function in sarcoma patients has completed with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2022-06-16Clinical Trial Update: A Study of Eribulin With Gemcitabine in Patients With Advanced Liposarcoma or Leiomyosarcoma [Phase 2]
Phase 2 clinical trial investigating eribulin in combination with gemcitabine for advanced liposarcoma or leiomyosarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors [Phase 1, Phase 2]
Phase 1/Phase 2 trial investigating dasatinib combined with ifosfamide, carboplatin, and etoposide in young patients with metastatic or recu…
-
EMA approval · 2022-01-11EMA Authorised: Beromun (tasonermin) — Belpharma s.a.
Beromun (tasonermin) has been authorised in the EU for use in sarcoma by Belpharma s.a.
-
CLINICAL_TRIALS trial_result · 2021-12-13Clinical Trial Update: A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors [Phase 1]
A Phase 1 dose-escalation study of PF-06801591 in multiple solid tumors including melanoma, head and neck cancer, ovarian cancer, sarcoma, n…
-
CLINICAL_TRIALS trial_result · 2021-10-08Clinical Trial Update: NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine [Phase 1]
Phase 1 clinical trial update for NY-ESO-1 plasmid DNA cancer vaccine pPJV7611 in multiple cancers with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2021-08-18Clinical Trial Update: TITAN (Tumoural Injection of T-VEC and Isolated Limb Perfusion) [Phase 1, Phase 2]
A phase 1/2 trial update evaluating Tumoural Injection of T-VEC with isolated limb perfusion in melanoma and sarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Rolapitant Hydrochloride in Preventing Nausea/Vomiting in Patients With Sarcoma Receiving Chemotherapy [Phase 2]
Phase 2 clinical trial investigating rolapitant hydrochloride to prevent nausea and vomiting in patients with locally advanced sarcoma under…
-
CLINICAL_TRIALS trial_result · 2021-05-26Clinical Trial Update: Pembrolizumab and Doxorubicin Hydrochloride in Treating Patients With Sarcoma That is Metastatic or Cannot Be Removed by Surgery [Phase 1, Phase 2]
Phase 1/2 trial evaluating pembrolizumab with doxorubicin in metastatic or unresectable sarcoma; study completed with results posted in 2021…